Show simple item record

dc.contributor.authorATAC Trialists' Group
dc.contributor.authorHowell, Anthony
dc.date.accessioned2009-10-02T12:09:47Z
dc.date.available2009-10-02T12:09:47Z
dc.date.issued2001
dc.identifier.citationPharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'ArimidexTM and Tamoxifen Alone or in Combination' (ATAC) trial. 2001, 85 : 317-324 Br J Canceren
dc.identifier.issn00070920
dc.identifier.issn15321827
dc.identifier.doi10.1054/bjoc.2001.1925
dc.identifier.urihttp://hdl.handle.net/10541/83336
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectArimidexen
dc.subjectTamoxifenen
dc.subjectAromataseen
dc.subjectOestrogenen
dc.titlePharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'ArimidexTM and Tamoxifen Alone or in Combination' (ATAC) trialen
dc.typeArticleen
dc.identifier.journalBritish Journal of Canceren


This item appears in the following Collection(s)

Show simple item record